Can BridgeBio Pharma Inc (BBIO) Stock Rise to the Top of Healthcare Sector Monday?

BridgeBio Pharma Inc (BBIO) is near the top in its sector according to InvestorsObserver. BBIO gets an overall rating of 84. That means it scores higher than 84% of stocks. BridgeBio Pharma Inc gets a 92 rank in the Healthcare sector. Healthcare is number 5 out of 11 sectors.

BBIO has an Overall Score of 84. Find out what this means to you and get the rest of the rankings on BBIO!

See Full BBIO Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 84 means the stock is more attractive than 84 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With BridgeBio Pharma Inc Stock Today?

BridgeBio Pharma Inc (BBIO) stock is higher by 0.24% while the S&P 500 is down -0.13% as of 11:35 AM on Monday, Nov 27. BBIO is higher by $0.07 from the previous closing price of $29.58 on volume of 250,547 shares. Over the past year the S&P 500 is up 14.88% while BBIO is higher by 266.05%. BBIO lost -$3.91 per share the over the last 12 months. Click Here to get the full Stock Report for BridgeBio Pharma Inc stock.